Advertisement

European Journal of Pediatrics

, Volume 152, Issue 7, pp 613–614 | Cite as

Guillain-Barré syndrome following immunisation withHaemophilus influenzae type b conjugate vaccine

  • A. Gervaix
  • M. Caflisch
  • S. Suter
  • Ch. -A. Haenggeli
Neuropediatrics

Abstract

The Guillain-Barré syndrome (GBS) is an immune-mediated disease often associated with viral or bacterial infections and with immunisation. IgM antibodies have been implicated as the main trigger event in GBS. So far, only four cases of GBS have been observed following immunisation with a conjugate vaccine againstHaemophilus influenzae type b. We report another patient with GBS after this vaccination. We measured immunoglobulins against theH. influenzae type b polysaccharide (PRP) component of the vaccine. Surprisingly the anti-PRP IgM antibody level was markedly elevated (100 μg/ml) in the plasma of this patient. We speculate that an excessive anti-PRP IgM antibody response to the vaccine might be the cause of GBS.

Key words

Haemophilus influenzae type b Vaccination Guillain-Barré syndrome 

Abbreviations

GBS

Guillain-Barré syndrome

PRP

polyribosyl-ribitol-phosphate

References

  1. 1.
    Asbury AK, Arnason BGW, Karp HR, McFarlin DE (1978) Criteria for diagnosis of Guillain-Barré syndrome. Ann Neurol 3:565–566CrossRefPubMedGoogle Scholar
  2. 2.
    Beghi E, Kurland LT, Mulder WD, Wiederholt WC (1985) Guillain-Barré syndrome: clinicoepidemiologic features and effect of influenza vaccine. Arch Neurol 42:1053–1057PubMedGoogle Scholar
  3. 3.
    D'Cruz ON, Shapiro ED, Spiegelman KN, et al (1989) Acute inflammatory demyelinating polyradiculopathy (Guillain-Barré syndrome) after immunization withHaemophilus influenzae type b conjugate vaccine. J Pediatr 115:743–746PubMedGoogle Scholar
  4. 4.
    Gross TP, Hayes SW (1991)Haemophilus conjugate vaccine and Guillain-Barré syndrome. J Pediatr 118:161Google Scholar
  5. 5.
    Ilyas AA, Willison HJ, Quarles RH, et al (1984) IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside. Proc Natl Acad Sci USA 81:1225–1229PubMedGoogle Scholar
  6. 6.
    Koski CL (1990) Characterization of complement-fixing antibodies to peripheral nerve myelin in Guillain-Barré syndrome. Ann Neurol 27:S44-S47CrossRefPubMedGoogle Scholar
  7. 7.
    Lepow ML, Samueslson JS, Gordon LK (1985) Safety and immunogenicity ofHaemophilus influenzae type b polysaccharide diphteria toxoid conjugate vaccine in infants 9 to 15 months of age. J Pediatr 106:185–189PubMedGoogle Scholar
  8. 8.
    McFarlin DE (1990) Immunological parameters in Guillain-Barré syndrome. Ann Neurol 27:S25-S29CrossRefPubMedGoogle Scholar
  9. 9.
    Shahar E, Murphy G, Roifman CM (1990) Benefit of intravenously administered immune serum globulin in patients with Guillain-Barré syndrome. J Pediatr 116:141–144PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • A. Gervaix
    • 1
  • M. Caflisch
    • 1
  • S. Suter
    • 1
  • Ch. -A. Haenggeli
    • 1
  1. 1.Children's HospitalUniversity Hospital of GenevaGenève 4Switzerland

Personalised recommendations